Phosphorex Overview
- Year Founded
-
2005
- Status
-
Private
- Latest Deal Type
-
Corporate
- Financing Rounds
-
3
Phosphorex General Information
Description
Operator of microspheres, nanoparticles, and drug delivery-focused contract development and manufacturing firm intended to provide drug delivery solutions for leading pharmaceutical and biotechnology companies around the world. The company offers formulation, feasibility, optimization, process development of polymeric particles and analytical services, thereby helping to optimize a drug's release rate, targeting ability, and bioavailability, helping healthcare professionals achieve desired therapeutic effects while reducing adverse clinical outcomes.
Contact Information
Website
www.phosphorex.comCorporate Office
- 35 Parkwood Drive
- Suite 150
- Hopkinton, MA 01748
- United States
Corporate Office
- 35 Parkwood Drive
- Suite 150
- Hopkinton, MA 01748
- United States
Phosphorex Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Phosphorex Comparisons
Industry
Financing
Details
Phosphorex Competitors (4)
One of Phosphorex’s 4 competitors is Kindeva Drug Delivery, a Private Equity-Backed company based in Woodbury, MN.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kindeva Drug Delivery | Private Equity-Backed | Woodbury, MN | ||||
| Ascendia Pharmaceuticals | Private Equity-Backed | North Brunswick, NJ | ||||
| Nemera | Private Equity-Backed | Lyon, France | ||||
| Genprice | Venture Capital-Backed | Potters Bar, United Kingdom |
Phosphorex Patents
Phosphorex Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022109279-A1 | Ion-pairing (ip) for producing microparticles | Inactive | 19-Nov-2020 | ||
| WO-2022108934-A1 | Novel drug delivery composition and process for blood-brain barrier crossing | Inactive | 17-Nov-2020 | ||
| WO-2022108937-A2 | Novel drug delivery composition and process for blood-brain barrier crossing | Inactive | 17-Nov-2020 | ||
| WO-2022108937-A3 | Novel drug delivery composition and process for blood-brain barrier crossing | Inactive | 17-Nov-2020 | ||
| WO-2022076435-A1 | Pharmaceutical composition of siglec-binding agents | Inactive | 05-Oct-2020 | A61P35/00 |
Phosphorex Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Phosphorex FAQs
-
When was Phosphorex founded?
Phosphorex was founded in 2005.
-
Where is Phosphorex headquartered?
Phosphorex is headquartered in Hopkinton, MA.
-
What industry is Phosphorex in?
Phosphorex’s primary industry is Drug Delivery.
-
Is Phosphorex a private or public company?
Phosphorex is a Private company.
-
What is Phosphorex’s current revenue?
The current revenue for Phosphorex is .
-
Who are Phosphorex’s investors?
NOF and Ampersand Capital Partners have invested in Phosphorex.
-
Who are Phosphorex’s competitors?
Kindeva Drug Delivery, Ascendia Pharmaceuticals, Nemera, and Genprice are competitors of Phosphorex.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process